Treatment Adherence in a Randomized Controlled Trial of Pirfenidone in HFpEF: Determinants and Impact on Efficacy-Reference-Cited by-同舟云学术

Treatment Adherence in a Randomized Controlled Trial of Pirfenidone in HFpEF: Determinants and Impact on Efficacy

Published:2023-07 Issue:7 Volume:29 Page:1091-1096
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Soltani FARDAD^ORCID,LEWIS GAVIN A.,ROSALA-HALLAS ANNA,DODD SUSANNA,SCHELBERT ERIK B.,WILLIAMS SIMON G.,CUNNINGTON COLIN,MCDONAGH THERESA,MILLER CHRISTOPHER A.

Funder

National Institute for Health and Care Research

British Heart Foundation

University of Manchester

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Non-adherence to heart failure medications predicts clinical outcomes: assessment in a single spot urine sample by liquid chromatography-tandem mass spectrometry (results of a prospective multicentre study);Gupta;Eur J Heart Fail,2021

2. Heart failure with preserved ejection fraction;Redfield;N Engl J Med,2016

3. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial;Lewis;Nature Med,2021

4. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial;Granger;Lancet,2005

5. Comparison of drug adherence rates among patients with seven different medical conditions;Briesacher;Pharmacotherapy,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis;Cells;2024-04-30

2. Pirfenidone increases transverse tubule length in the infarcted rat myocardium;Interface Focus;2023-12-15